Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Novel Multiplex PCR Based Detection Assay Using Saliva or Nasopharyngeal Samples for SARS-Cov-2, Influenza A and B – Clinical Validation and Utility for Mass Surveillance

Nikhil S Sahajpal, Ashis K Mondal, Sudha Ananth, Allan Njau, Pankaj Ahluwalia, Eesha Oza, Ted M Ross, Vamsi Kota, Arvind Kothandaraman, Sadanand Fulzele, Madhuri Hegde, Alka Chaubey, Amyn M Rojiani, View ORCID ProfileRavindra Kolhe
doi: https://doi.org/10.1101/2021.01.13.21249629
Nikhil S Sahajpal
1Department of Pathology, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashis K Mondal
1Department of Pathology, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudha Ananth
1Department of Pathology, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan Njau
2Department of Pathology, Aga Khan University Hospital, Nairobi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pankaj Ahluwalia
1Department of Pathology, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eesha Oza
1Department of Pathology, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ted M Ross
4Department of Medicine, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vamsi Kota
4Department of Medicine, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arvind Kothandaraman
6Global Laboratory Services, Perkin Elmer, Waltham, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sadanand Fulzele
5Center for Healthy Aging, Medical College of Georgia, Augusta University, Augusta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madhuri Hegde
6Global Laboratory Services, Perkin Elmer, Waltham, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alka Chaubey
1Department of Pathology, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amyn M Rojiani
1Department of Pathology, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravindra Kolhe
1Department of Pathology, Medical College of Georgia, Augusta University, GA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ravindra Kolhe
  • For correspondence: rkolhe@augusta.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The COVID-19 pandemic has resulted in a significant diversion of human and material resources to COVID-19 diagnostics, to the extent that testing of viral pathogens normally contributing to seasonal respiratory tract infections have been markedly neglected. The global health burden due to influenza viruses and co-infection in COVID-19 patients remains undocumented but clearly pose serious public health consequences. To address these clinical and technical challenges, we have optimized and validated a highly sensitive RT-PCR based multiplex assay for the detection of SARS-CoV-2, Influenza A and B viruses in a single test.

Methods This study evaluated clinical specimens (n=1411) that included 1019 saliva and 392 nasopharyngeal swab (NPS) samples collected in either healthcare or community setting. Samples were tested using two assays: FDA-EUA approved SARS-CoV-2 assay that targets N and ORF1ab gene, and the PKamp RT-PCR based assay that targets SARS-CoV-2, Influenza viruses A and B. The limit of detection (LoD) studies was conducted as per the FDA guidelines using SARS-CoV-2 and Influenza A and B reference control materials.

Results Of the 1019 saliva samples, 17.0% (174/1019) tested positive for SARS-CoV-2 using either assay. The detection rate for SARS-CoV-2 was higher with our multiplex assay compared to SARS-specific assay [91.9% (160/174) vs. 87.9% (153/174)], respectively. Of the 392 NPS samples, 10.4% (41/392) tested positive for SARS-CoV-2 using either assay. The detection rate for SARS-CoV-2 was higher with our multiplex assay compared to SARS-specific assay [97.5% (40/41) vs. 92.1% (39/41)], respectively. The Ct values for SARS-CoV-2 were comparable between the two assays, whereas the Ct values of the housekeeping gene was significantly lower with multiplex assay compared to SARS-specific assay. The LoD was established as 60 copies/ml for SARS-CoV-2 and 180 copies/ml for Influenza A and B viruses for both saliva and NPS samples.

Conclusion This study presents clinical validation of a multiplex PCR assay for testing SARS-CoV-2, Influenza A and B viruses, using NPS and saliva samples, and demonstrates the feasibility of implementing the assay without disrupting the existing laboratory workflow. This novel assay uses the same instruments, sample types, supplies, and laboratory personnel as needed for the testing of SARS-CoV-2 virus.

Competing Interest Statement

RK has received honoraria, travel funding, and research support from Illumina, Asuragen, QIAGEN, Perkin Elmer and BMS. AK is salaried employee of Perkin Elmer. MH hold stock options at PerkinElmer Inc.

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The samples were processed under an approved HAC by the IRB Committee A (IRB REGISTRATION # 611298), Augusta University, GA. Based on the IRB approval, all PHI was removed and all data was anonymized before accessing for the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All relevant data is provided in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Novel Multiplex PCR Based Detection Assay Using Saliva or Nasopharyngeal Samples for SARS-Cov-2, Influenza A and B – Clinical Validation and Utility for Mass Surveillance
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Novel Multiplex PCR Based Detection Assay Using Saliva or Nasopharyngeal Samples for SARS-Cov-2, Influenza A and B – Clinical Validation and Utility for Mass Surveillance
Nikhil S Sahajpal, Ashis K Mondal, Sudha Ananth, Allan Njau, Pankaj Ahluwalia, Eesha Oza, Ted M Ross, Vamsi Kota, Arvind Kothandaraman, Sadanand Fulzele, Madhuri Hegde, Alka Chaubey, Amyn M Rojiani, Ravindra Kolhe
medRxiv 2021.01.13.21249629; doi: https://doi.org/10.1101/2021.01.13.21249629
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Novel Multiplex PCR Based Detection Assay Using Saliva or Nasopharyngeal Samples for SARS-Cov-2, Influenza A and B – Clinical Validation and Utility for Mass Surveillance
Nikhil S Sahajpal, Ashis K Mondal, Sudha Ananth, Allan Njau, Pankaj Ahluwalia, Eesha Oza, Ted M Ross, Vamsi Kota, Arvind Kothandaraman, Sadanand Fulzele, Madhuri Hegde, Alka Chaubey, Amyn M Rojiani, Ravindra Kolhe
medRxiv 2021.01.13.21249629; doi: https://doi.org/10.1101/2021.01.13.21249629

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (239)
  • Allergy and Immunology (521)
  • Anesthesia (124)
  • Cardiovascular Medicine (1418)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10288)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2625)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1729)
  • Health Policy (789)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12083)
  • Intensive Care and Critical Care Medicine (648)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (288)
  • Neurology (2456)
  • Nursing (144)
  • Nutrition (377)
  • Obstetrics and Gynecology (491)
  • Occupational and Environmental Health (566)
  • Oncology (1319)
  • Ophthalmology (400)
  • Orthopedics (146)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (778)
  • Pharmacology and Therapeutics (329)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2394)
  • Public and Global Health (4999)
  • Radiology and Imaging (893)
  • Rehabilitation Medicine and Physical Therapy (525)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (255)
  • Sports Medicine (244)
  • Surgery (297)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)